By Deron Hamel The Ontario government is asking for input from people who have had experience living with uncontrolled focal onset seizures for an upcoming assessment of a new anti-seizure drug. An expert committee, established by the province to review medications, will assess this input along with clinical trial data and an economic evaluation of…
By Deron Hamel Epilepsy Ontario is urging people taking 250-mg soft-gel capsules of the anti-seizure medication Zarontin (ethosuximide) to closely scrutinize their capsules to ensure they are not defective, following a warning issued by Erfa Canada 2012 Inc. and Health Canada. Erfa Canada 2012 Inc., the company that manufactures Zarontin, and Health Canada have received…
By Deron Hamel Epilepsy Ontario announced today that it has entered a partnership with EpLink to fund a study to research the link between brain trauma and the development of epilepsy. There is a body of evidence that shows people who suffer brain trauma are at increased risk of developing epilepsy. What is not known…
By Deron Hamel Adam Prashaw went through life facing many challenges but always persevered. On Jan. 24, Adam, 22, tragically died after suffering a seizure in his hot tub at his Ottawa home. But his story doesn’t stop there. One day later and more than 500 kilometres away, in Welland, Ont., a 53-year-old man was…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
